estriol has been researched along with Atrophic Vaginitis in 3 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Atrophic Vaginitis: Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In postmenopausal women, the combination of HA, CS, curcumin and quercetin per os was effective in preventing recurrent urinary tract infections, especially if administered with vaginal estrogen therapy." | 9.22 | Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. ( Colacurci, N; De Franciscis, P; Del Deo, F; Gallo, P; Grimaldi, A; Iervolino, SA; Pezzella, M; Rappa, C; Tammaro, C; Torella, M, 2016) |
| "In postmenopausal women, the combination of HA, CS, curcumin and quercetin per os was effective in preventing recurrent urinary tract infections, especially if administered with vaginal estrogen therapy." | 5.22 | Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. ( Colacurci, N; De Franciscis, P; Del Deo, F; Gallo, P; Grimaldi, A; Iervolino, SA; Pezzella, M; Rappa, C; Tammaro, C; Torella, M, 2016) |
| " Safety assessments included vital signs, laboratory examinations of the vaginal microecosystem, vaginal pH value, vaginal B ultrasound, and incidence of adverse events." | 2.78 | Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. ( Chen, J; Geng, L; Giordan, N; Li, H; Liao, Q; Song, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Geng, L | 1 |
| Song, X | 1 |
| Li, H | 1 |
| Giordan, N | 1 |
| Liao, Q | 1 |
| Torella, M | 1 |
| Del Deo, F | 1 |
| Grimaldi, A | 1 |
| Iervolino, SA | 1 |
| Pezzella, M | 1 |
| Tammaro, C | 1 |
| Gallo, P | 1 |
| Rappa, C | 1 |
| De Franciscis, P | 1 |
| Colacurci, N | 1 |
| LAURICELLA, E | 1 |
| ALESIANI, ML | 1 |
2 trials available for estriol and Atrophic Vaginitis
| Article | Year |
|---|---|
Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
Topics: Administration, Intravaginal; Adult; Aged; Atrophic Vaginitis; China; Estriol; Female; Humans; Hyalu | 2013 |
Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Topics: Aging; Anti-Infective Agents, Urinary; Antioxidants; Atrophic Vaginitis; Chondroitin Sulfates; Combi | 2016 |
1 other study available for estriol and Atrophic Vaginitis
| Article | Year |
|---|---|
[Estriol by oral, parenteral and local route in atrophic vaginitis of the menopause].
Topics: Atrophic Vaginitis; Estriol; Estrogens; Female; Humans; Menopause; Postmenopause; Vaginitis | 1961 |